Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Hydration Baseline Day 1 |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Hydration Baseline Day 2 |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Hydration Baseline Day 3 |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the 30 minute mark. |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the 90 minute mark. |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Fluid Retention - Change in Expelled Urine Volume |
Assessment of fluid retention via collection of urine volume |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Hydration Baseline Day 1 |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Hydration Baseline Day 2 |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Hydration Baseline Day 3 |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Kidney Function - Change in Aldosterone Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Hydration Baseline Day 1 |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Hydration Baseline Day 2 |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Hydration Baseline Day 3 |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Kidney Function - Change in Copeptin Response |
Assessment of kidney function in regards to fluid retention via assessment of blood biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Hydration Baseline Day 1 |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Hydration Baseline Day 2 |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Hydration Baseline Day 3 |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Kidney Function - Change in Creatinine Response |
Assessment of kidney function in regards to fluid retention via assessment of urine biomarkers associated with kidney function |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 1 |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 2 |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 3 |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -75 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -60 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Change in Whole Blood Sodium Levels |
Assessment of fluid retention via whole blood sodium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 1 |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 2 |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 3 |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -75 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -60 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Change in Whole Blood Potassium Levels |
Assessment of fluid retention via whole blood potassium (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 1 |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 2 |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Hydration Baseline Day 3 |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -75 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -60 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Primary |
Change in Whole Blood Chloride Levels |
Assessment of fluid retention via whole blood chloride (electrolyte levels) through blood biomarkers |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Hydration Baseline 1 |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Hydration Baseline 2 |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Hydration Baseline 3 |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the -75 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the -60 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hematocrit Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hematocrit levels |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Hydration Baseline Day 1 |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Hydration Baseline Day 2 |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Hydration Baseline Day 3 |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the -75 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the -60 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Fluid Retention - Change in Whole Blood Hemoglobin Levels |
Assessment of plasma volume shifts which may indicate fluid retention via assessment of changes in hemoglobin levels |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Hydration Baseline Day 1 |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Hydration Baseline Day 2 |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Hydration Baseline Day 3 |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the -75 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the -60 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the -30 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Fluid Retention - Change in Plasma Osmolality Shifts |
Assessment of fluid retention via changes in plasma osmolality |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 1 |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 2 |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 3 |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 30 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 90 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 150 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Color |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 1 |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 2 |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 3 |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 30 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 90 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 150 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Specific Gravity |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 1 |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 2 |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Hydration Baseline Day 3 |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 30 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 90 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 150 minute mark. |
|
Secondary |
Kidney Function - Change in Urine Osmolality |
Assessment of kidney function via urine biomarkers collected during data procedures. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Cardiovascular Function - Change in Blood Pressure |
Assessment of cardiovascular function via blood pressure changes during data collection procedures |
Hydration Baseline Day 1 |
|
Secondary |
Cardiovascular Function - Change in Blood Pressure |
Assessment of cardiovascular function via blood pressure changes during data collection procedures |
Intervention Trial (Day 4) at the -90 minute mark. |
|
Secondary |
Cardiovascular Function - Change in Blood Pressure |
Assessment of cardiovascular function via blood pressure changes during data collection procedures |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Cardiovascular Function - Change in Blood Pressure |
Assessment of cardiovascular function via blood pressure changes during data collection procedures |
Intervention Trial (Day 4) at the 30 minute mark. |
|
Secondary |
Cardiovascular Function - Change in Blood Pressure |
Assessment of cardiovascular function via blood pressure changes during data collection procedures |
Intervention Trial (Day 4) at the 90 minute mark. |
|
Secondary |
Cardiovascular Function - Change in Blood Pressure |
Assessment of cardiovascular function via blood pressure changes during data collection procedures |
Intervention Trial (Day 4) at the 150 minute mark. |
|
Secondary |
Cardiovascular Function - Change in Heart Rate Variability |
Assessment of cardiovascular function via heart rate variability changes during data collection procedures |
Hydration Baseline Day 2 |
|
Secondary |
Cardiovascular Function - Change in Heart Rate Variability |
Assessment of cardiovascular function via heart rate variability changes during data collection procedures |
Intervention Trial (Day 4) at the -90 minute mark |
|
Secondary |
Cardiovascular Function - Change in Heart Rate Variability |
Assessment of cardiovascular function via heart rate variability changes during data collection procedures |
Intervention Trial (Day 4) at the 0 minute mark |
|
Secondary |
Cardiovascular Function - Change in Heart Rate Variability |
Assessment of cardiovascular function via heart rate variability changes during data collection procedures |
Intervention Trial (Day 4) at the 30 minute mark |
|
Secondary |
Cardiovascular Function - Change in Heart Rate Variability |
Assessment of cardiovascular function via heart rate variability changes during data collection procedures |
Intervention Trial (Day 4) at the 90 minute mark |
|
Secondary |
Cardiovascular Function - Change in Heart Rate Variability |
Assessment of cardiovascular function via heart rate variability changes during data collection procedures |
Intervention Trial (Day 4) at the 150 minute mark |
|
Secondary |
Cardiovascular Function - Change in Resting Heart Rate |
Assessment of cardiovascular function via resting heart rate changes during data collection procedures |
Intervention Trial (Day 4) |
|
Secondary |
Cognitive Differences - Changes in Go/No Go Assessment |
This test will be used for the assessment of response inhibition. For completion of the test, the participant will be presented with two characters, "x" and "o", and will be expected to either respond as quickly as possible ("x") or not ("o") depending on the visual stimulus provided. |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Go/No Go Assessment |
This test will be used for the assessment of response inhibition. For completion of the test, the participant will be presented with two characters, "x" and "o", and will be expected to either respond as quickly as possible ("x") or not ("o") depending on the visual stimulus provided. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Go/No Go Assessment |
This test will be used for the assessment of response inhibition. For completion of the test, the participant will be presented with two characters, "x" and "o", and will be expected to either respond as quickly as possible ("x") or not ("o") depending on the visual stimulus provided. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Go/No Go Assessment |
This test will be used for the assessment of response inhibition. For completion of the test, the participant will be presented with two characters, "x" and "o", and will be expected to either respond as quickly as possible ("x") or not ("o") depending on the visual stimulus provided. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Go/No Go Assessment |
This test will be used for the assessment of response inhibition. For completion of the test, the participant will be presented with two characters, "x" and "o", and will be expected to either respond as quickly as possible ("x") or not ("o") depending on the visual stimulus provided. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Cognitive Differences - Changes in 2 Choice Reaction Time |
This test will be used for the assessment of attention and processing speed when presented with the opportunity to make a simple choice. The test will include a "*" or "o" which will be presented on the computer screen display. The participant will be instructed to respond as quickly as possible by pressing the designated button for each stimulus as it appears on the screen. |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Cognitive Differences - Changes in 2 Choice Reaction Time |
This test will be used for the assessment of attention and processing speed when presented with the opportunity to make a simple choice. The test will include a "*" or "o" which will be presented on the computer screen display. The participant will be instructed to respond as quickly as possible by pressing the designated button for each stimulus as it appears on the screen. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Cognitive Differences - Changes in 2 Choice Reaction Time |
This test will be used for the assessment of attention and processing speed when presented with the opportunity to make a simple choice. The test will include a "*" or "o" which will be presented on the computer screen display. The participant will be instructed to respond as quickly as possible by pressing the designated button for each stimulus as it appears on the screen. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Cognitive Differences - Changes in 2 Choice Reaction Time |
This test will be used for the assessment of attention and processing speed when presented with the opportunity to make a simple choice. The test will include a "*" or "o" which will be presented on the computer screen display. The participant will be instructed to respond as quickly as possible by pressing the designated button for each stimulus as it appears on the screen. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Cognitive Differences - Changes in 2 Choice Reaction Time |
This test will be used for the assessment of attention and processing speed when presented with the opportunity to make a simple choice. The test will include a "*" or "o" which will be presented on the computer screen display. The participant will be instructed to respond as quickly as possible by pressing the designated button for each stimulus as it appears on the screen. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Procedural Reaction Time |
This test will be associated with the comprehension of a simple set of rules provided to participants during testing completion and will be used for the assessment of reaction time and processing efficiency. Participants will be presented with a number constructed using a large dot matrix on the computer display. Participants will be tasked with pressing a button correctly designated towards the identification of a "low" number or "high" number. |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Procedural Reaction Time |
This test will be associated with the comprehension of a simple set of rules provided to participants during testing completion and will be used for the assessment of reaction time and processing efficiency. Participants will be presented with a number constructed using a large dot matrix on the computer display. Participants will be tasked with pressing a button correctly designated towards the identification of a "low" number or "high" number. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Procedural Reaction Time |
This test will be associated with the comprehension of a simple set of rules provided to participants during testing completion and will be used for the assessment of reaction time and processing efficiency. Participants will be presented with a number constructed using a large dot matrix on the computer display. Participants will be tasked with pressing a button correctly designated towards the identification of a "low" number or "high" number. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Procedural Reaction Time |
This test will be associated with the comprehension of a simple set of rules provided to participants during testing completion and will be used for the assessment of reaction time and processing efficiency. Participants will be presented with a number constructed using a large dot matrix on the computer display. Participants will be tasked with pressing a button correctly designated towards the identification of a "low" number or "high" number. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Procedural Reaction Time |
This test will be associated with the comprehension of a simple set of rules provided to participants during testing completion and will be used for the assessment of reaction time and processing efficiency. Participants will be presented with a number constructed using a large dot matrix on the computer display. Participants will be tasked with pressing a button correctly designated towards the identification of a "low" number or "high" number. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Stroop Test |
This test will be used for the assessment of processing speed, selective attention, interference, and executive functioning skills by correctly identifying either the word- or color-based stimuli presented on the computer screen. |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Stroop Test |
This test will be used for the assessment of processing speed, selective attention, interference, and executive functioning skills by correctly identifying either the word- or color-based stimuli presented on the computer screen. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Stroop Test |
This test will be used for the assessment of processing speed, selective attention, interference, and executive functioning skills by correctly identifying either the word- or color-based stimuli presented on the computer screen. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Stroop Test |
This test will be used for the assessment of processing speed, selective attention, interference, and executive functioning skills by correctly identifying either the word- or color-based stimuli presented on the computer screen. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Cognitive Differences - Changes in Stroop Test |
This test will be used for the assessment of processing speed, selective attention, interference, and executive functioning skills by correctly identifying either the word- or color-based stimuli presented on the computer screen. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Environmental Symptoms Questionnaire |
A modified version of the 68-item questionnaire will be administered. This is a test to monitor for symptoms of exertional heat illness (i.e. headache, dizziness, nausea, thirst, cramps, etc.) and will be administered during all sessions performed within environmental conditions. |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Environmental Symptoms Questionnaire |
A modified version of the 68-item questionnaire will be administered. This is a test to monitor for symptoms of exertional heat illness (i.e. headache, dizziness, nausea, thirst, cramps, etc.) and will be administered during all sessions performed within environmental conditions. |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Environmental Symptoms Questionnaire |
A modified version of the 68-item questionnaire will be administered. This is a test to monitor for symptoms of exertional heat illness (i.e. headache, dizziness, nausea, thirst, cramps, etc.) and will be administered during all sessions performed within environmental conditions. |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Environmental Symptoms Questionnaire |
A modified version of the 68-item questionnaire will be administered. This is a test to monitor for symptoms of exertional heat illness (i.e. headache, dizziness, nausea, thirst, cramps, etc.) and will be administered during all sessions performed within environmental conditions. |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Environmental Symptoms Questionnaire |
A modified version of the 68-item questionnaire will be administered. This is a test to monitor for symptoms of exertional heat illness (i.e. headache, dizziness, nausea, thirst, cramps, etc.) and will be administered during all sessions performed within environmental conditions. |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Fatigue Scale |
This scale has been associated with good face validity and high levels of convergent validity during exhaustive exercise.16 It consists of an eleven-point (0-10) Likert Scale with verbal anchors of 0, "No Fatigue At All", 1, "Very Small Amount of Fatigue", 2, "Small Amount of Fatigue", 3, "Moderate Fatigue", 4, "Somewhat Fatigued", 5, "Fatigued", 7, "Very Fatigued", 9, "Extremely Fatigued", and 10, "Completely Fatigued" |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Fatigue Scale |
This scale has been associated with good face validity and high levels of convergent validity during exhaustive exercise.16 It consists of an eleven-point (0-10) Likert Scale with verbal anchors of 0, "No Fatigue At All", 1, "Very Small Amount of Fatigue", 2, "Small Amount of Fatigue", 3, "Moderate Fatigue", 4, "Somewhat Fatigued", 5, "Fatigued", 7, "Very Fatigued", 9, "Extremely Fatigued", and 10, "Completely Fatigued" |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Fatigue Scale |
This scale has been associated with good face validity and high levels of convergent validity during exhaustive exercise.16 It consists of an eleven-point (0-10) Likert Scale with verbal anchors of 0, "No Fatigue At All", 1, "Very Small Amount of Fatigue", 2, "Small Amount of Fatigue", 3, "Moderate Fatigue", 4, "Somewhat Fatigued", 5, "Fatigued", 7, "Very Fatigued", 9, "Extremely Fatigued", and 10, "Completely Fatigued" |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Fatigue Scale |
This scale has been associated with good face validity and high levels of convergent validity during exhaustive exercise.16 It consists of an eleven-point (0-10) Likert Scale with verbal anchors of 0, "No Fatigue At All", 1, "Very Small Amount of Fatigue", 2, "Small Amount of Fatigue", 3, "Moderate Fatigue", 4, "Somewhat Fatigued", 5, "Fatigued", 7, "Very Fatigued", 9, "Extremely Fatigued", and 10, "Completely Fatigued" |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Fatigue Scale |
This scale has been associated with good face validity and high levels of convergent validity during exhaustive exercise.16 It consists of an eleven-point (0-10) Likert Scale with verbal anchors of 0, "No Fatigue At All", 1, "Very Small Amount of Fatigue", 2, "Small Amount of Fatigue", 3, "Moderate Fatigue", 4, "Somewhat Fatigued", 5, "Fatigued", 7, "Very Fatigued", 9, "Extremely Fatigued", and 10, "Completely Fatigued" |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Gastrointestinal Distress Scale |
To measure potential gastrointestinal distress or discomfort, a combination of scales will be used including a numeric rating scale (NRS) and the patient's global impression of change (PGIC) scale. The NRS measurement tool has been well psychometrically tested with irritable bowel syndrome (IBS) patients while demonstrating appropriate correlations with GI-symptom severity and excellent construct and discriminant validity for clinical assessments of abdominal pain. This scale will be comprised of a ten-point abdominal pain numeric rating scale with verbal anchors of 1, "None" and 10, "Very Severe".15,23 Furthermore, the PGIC scale has been documented as a commonly used and validated measure of pain. This scale will be comprised of an eight-point Likert scale with verbal anchors of 1, "Very Much Improved", 2, "Much Improved", 3, "Minimally Improved", 4, "No Change", 5, "Minimally Worse", 6, "Much Worse", and 7, "Very Much Worse" |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Gastrointestinal Distress Scale |
To measure potential gastrointestinal distress or discomfort, a combination of scales will be used including a numeric rating scale (NRS) and the patient's global impression of change (PGIC) scale. The NRS measurement tool has been well psychometrically tested with irritable bowel syndrome (IBS) patients while demonstrating appropriate correlations with GI-symptom severity and excellent construct and discriminant validity for clinical assessments of abdominal pain. This scale will be comprised of a ten-point abdominal pain numeric rating scale with verbal anchors of 1, "None" and 10, "Very Severe".15,23 Furthermore, the PGIC scale has been documented as a commonly used and validated measure of pain. This scale will be comprised of an eight-point Likert scale with verbal anchors of 1, "Very Much Improved", 2, "Much Improved", 3, "Minimally Improved", 4, "No Change", 5, "Minimally Worse", 6, "Much Worse", and 7, "Very Much Worse" |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Gastrointestinal Distress Scale |
To measure potential gastrointestinal distress or discomfort, a combination of scales will be used including a numeric rating scale (NRS) and the patient's global impression of change (PGIC) scale. The NRS measurement tool has been well psychometrically tested with irritable bowel syndrome (IBS) patients while demonstrating appropriate correlations with GI-symptom severity and excellent construct and discriminant validity for clinical assessments of abdominal pain. This scale will be comprised of a ten-point abdominal pain numeric rating scale with verbal anchors of 1, "None" and 10, "Very Severe".15,23 Furthermore, the PGIC scale has been documented as a commonly used and validated measure of pain. This scale will be comprised of an eight-point Likert scale with verbal anchors of 1, "Very Much Improved", 2, "Much Improved", 3, "Minimally Improved", 4, "No Change", 5, "Minimally Worse", 6, "Much Worse", and 7, "Very Much Worse" |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Gastrointestinal Distress Scale |
To measure potential gastrointestinal distress or discomfort, a combination of scales will be used including a numeric rating scale (NRS) and the patient's global impression of change (PGIC) scale. The NRS measurement tool has been well psychometrically tested with irritable bowel syndrome (IBS) patients while demonstrating appropriate correlations with GI-symptom severity and excellent construct and discriminant validity for clinical assessments of abdominal pain. This scale will be comprised of a ten-point abdominal pain numeric rating scale with verbal anchors of 1, "None" and 10, "Very Severe".15,23 Furthermore, the PGIC scale has been documented as a commonly used and validated measure of pain. This scale will be comprised of an eight-point Likert scale with verbal anchors of 1, "Very Much Improved", 2, "Much Improved", 3, "Minimally Improved", 4, "No Change", 5, "Minimally Worse", 6, "Much Worse", and 7, "Very Much Worse" |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Gastrointestinal Distress Scale |
To measure potential gastrointestinal distress or discomfort, a combination of scales will be used including a numeric rating scale (NRS) and the patient's global impression of change (PGIC) scale. The NRS measurement tool has been well psychometrically tested with irritable bowel syndrome (IBS) patients while demonstrating appropriate correlations with GI-symptom severity and excellent construct and discriminant validity for clinical assessments of abdominal pain. This scale will be comprised of a ten-point abdominal pain numeric rating scale with verbal anchors of 1, "None" and 10, "Very Severe".15,23 Furthermore, the PGIC scale has been documented as a commonly used and validated measure of pain. This scale will be comprised of an eight-point Likert scale with verbal anchors of 1, "Very Much Improved", 2, "Much Improved", 3, "Minimally Improved", 4, "No Change", 5, "Minimally Worse", 6, "Much Worse", and 7, "Very Much Worse" |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thermal Sensation Scale |
This scale will be used for the measurement of participant perceptions of heat stress during data collection procedures. The Thermal Sensation Scale is a nine-point (0.0-8.0) Likert Scale with verbal anchors at 0.0, "Unbearably Cold", 1.0, "Very Cold", 2.0, "Cold", 3.0, "Cool", 4.0, "Comfortable", 5.0 "Warm", 6.0, "Hot", 7.0, "Very Hot", and 8.0, "Unbearably Hot" |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thermal Sensation Scale |
This scale will be used for the measurement of participant perceptions of heat stress during data collection procedures. The Thermal Sensation Scale is a nine-point (0.0-8.0) Likert Scale with verbal anchors at 0.0, "Unbearably Cold", 1.0, "Very Cold", 2.0, "Cold", 3.0, "Cool", 4.0, "Comfortable", 5.0 "Warm", 6.0, "Hot", 7.0, "Very Hot", and 8.0, "Unbearably Hot" |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thermal Sensation Scale |
This scale will be used for the measurement of participant perceptions of heat stress during data collection procedures. The Thermal Sensation Scale is a nine-point (0.0-8.0) Likert Scale with verbal anchors at 0.0, "Unbearably Cold", 1.0, "Very Cold", 2.0, "Cold", 3.0, "Cool", 4.0, "Comfortable", 5.0 "Warm", 6.0, "Hot", 7.0, "Very Hot", and 8.0, "Unbearably Hot" |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thermal Sensation Scale |
This scale will be used for the measurement of participant perceptions of heat stress during data collection procedures. The Thermal Sensation Scale is a nine-point (0.0-8.0) Likert Scale with verbal anchors at 0.0, "Unbearably Cold", 1.0, "Very Cold", 2.0, "Cold", 3.0, "Cool", 4.0, "Comfortable", 5.0 "Warm", 6.0, "Hot", 7.0, "Very Hot", and 8.0, "Unbearably Hot" |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thermal Sensation Scale |
This scale will be used for the measurement of participant perceptions of heat stress during data collection procedures. The Thermal Sensation Scale is a nine-point (0.0-8.0) Likert Scale with verbal anchors at 0.0, "Unbearably Cold", 1.0, "Very Cold", 2.0, "Cold", 3.0, "Cool", 4.0, "Comfortable", 5.0 "Warm", 6.0, "Hot", 7.0, "Very Hot", and 8.0, "Unbearably Hot" |
Intervention Trial (Day 4) at the 180 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Hydration Baseline Day 1 |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Hydration Baseline Day 2 |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Hydration Baseline Day 3 |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Intervention Trial (Day 4) at the -115 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Intervention Trial (Day 4) at the 0 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Intervention Trial (Day 4) at the 60 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Intervention Trial (Day 4) at the 120 minute mark. |
|
Secondary |
Perceptual Differences - Changes in Thirst Perception Scale |
A nine-point (1-9) Likert Scale which provides verbal anchors of 1, "Not Thirsty at All"; 3, "A Little Thirsty"; 5, "Moderately Thirsty"; 7, "Very Thirsty"; and 9, "Very, Very Thirsty" |
Intervention Trial (Day 4) at the 180 minute mark. |
|